立止血在外伤性脾破裂非手术治疗中应用的临床研究  

Clinical study of hemocoagulase on non-operative treatment of traumatic splenic broken

作　　者：卢华军[1] 刘文娟[1] 王凤娟[1] 谭炜炜[1] 高丽丽[1] 陈曦[1] 张学林[1] 陈敏胜[1] 曲永柏[1] 

机构地区：[1]烟台市莱阳中心医院外二科,烟台265200

出　　处：《中国医疗前沿》2009年第17期36-37,共2页China Healthcare Innovation

摘　　要：目的比较两种立止血用法在外伤性脾破裂非手术治疗中的止血效果。方法64例外伤性脾破裂患者随机分成两组,分别于入院后应用立止血3天、7天,观察两种用法对外伤性脾破裂患者住院后定期(第3天、第7天、第14天、第21天、第28天)血常规、腹部彩超检查、并发症等方面的影响。结果两组患者在住院后定期血常规、腹部彩超检查、并发症等方面差异无统计学意义。结论外伤性脾破裂非手术治疗中的止血药物应用7天和3天的效果基本相同,应用3天可能就已足够。Objective To compare the effect of hemostasia of two methods of hemocoagulase on non-operative treatment of traumatic splenic broken. Methods 64 cases of traumatic splenic broken were divided into two groups randomly, Hemocoagulase were used differently three or seven days after admission, blood routine examination,blood coagulation routine examination, abdomen examLqation of color ultrasound, and complication of traumatic splenic broken were observed on the third day, the seven day, the fourteenth day, the twenty-first day and the twenty-eigth day. Results Two groups had no significance on blood routine examination, blood coagulation routine examination, abdomen examination of color ultrasound, and complication. Conclusion The effect of seven days and three days of methods of hemostasia medication on treatment of traumatic splenic broken were uniform, so three days was enough.

关 键 词：外伤性脾破裂 非手术治疗 立止血 

分 类 号：R657.62[医药卫生—外科学]